Harvard Bioscience Inc balance sheet

At the end of fiscal 2025, Harvard Bioscience Inc had total assets of $80.1m, total liabilities of $66.3m and shareholders' equity of $13.7m. It held $8.6m in cash against $40.0m of debt: net debt of $31.4m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Harvard Bioscience Inc: balance sheet, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	17	20	18	21	26	14	7	6	6	8	8	8	8	5	4	4	9	7
Receivables	—	15	15	14	14	16	18	16	13	21	21	18	22	17	16	15	16	15
Inventory	—	16	18	18	16	21	22	20	17	25	22	22	28	26	25	23	21	22
Total current assets	—	59	58	59	61	57	51	45	48	58	54	52	62	51	49	45	48	46
Goodwill	—	33	34	36	37	40	40	38	36	57	57	59	58	56	57	56	10	9
Total assets	—	125	127	133	135	136	120	108	109	169	165	156	162	145	137	127	80	76
Accounts payable	—	5	5	5	5	6	9	6	4	7	5	6	5	6	6	5	4	6
Deferred revenue (current)	—	0	0	0	1	1	1	1	1	4	4	4	4	3	5	4	3	4
Total current liabilities	—	11	10	10	16	18	19	15	14	25	25	21	25	23	27	55	22	25
Short-term debt	—	—	—	—	—	—	—	—	—	2	3	2	4	4	6	37	0	0
Long-term debt	—	18	16	13	20	16	16	11	9	55	47	46	45	43	31	0	36	37
Total debt	0	18	16	13	25	21	19	14	12	61	55	49	49	48	37	37	40	37
Total liabilities	—	35	31	29	41	40	42	36	28	86	83	80	79	73	64	63	66	69
Shareholders' equity	75	90	95	104	94	95	78	72	81	83	82	77	83	72	73	63	14	7
Net debt (negative = net cash)	−17	−2	−2	−8	−1	7	12	8	6	53	47	41	42	43	33	33	31	30
Shares outstanding	—	28m	29m	29m	32m	33m	34m	35m	35m	37m	38m	39m	41m	42m	43m	44m	45m	5m

US$ millions unless shown otherwise. Fiscal quarters.

Harvard Bioscience Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	13	15	13	12	12	16	15	15
Inventory	26	23	23	22	22	21	22	22
Total current assets	47	45	45	45	44	48	47	46
Goodwill	57	56	9	10	10	10	9	9
Total assets	131	127	80	80	78	80	78	76
Accounts payable	5	5	5	5	5	4	5	6
Deferred revenue (current)	4	4	3	3	3	3	4	4
Total current liabilities	23	55	56	55	54	22	24	25
Short-term debt	4	37	—	—	—	0	0	0
Long-term debt	34	0	36	35	34	36	36	37
Total debt	38	37	36	35	34	36	36	37
Total liabilities	66	63	65	64	64	66	68	69
Shareholders' equity	65	63	15	16	14	14	10	7
Shares outstanding	44m	44m	44m	45m	45m	4m	5m	5m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CDXS vs HBIO BNR vs HBIO BDSX vs HBIO HBIO vs MDXH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Harvard Bioscience Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Harvard Bioscience Inc.